60例2型糖尿病合并冠心病患者中医证候分析
|
摘要
[目的]分析总结2型糖尿病合并冠心病患者中医证候特点,初步探索2型糖尿病合并冠心病中医辨证规律,为中医证候研究提供有益参考。
[方法]调查2007年1月～2009年12月于北京医院中医科门诊及病房诊治的2型糖尿病合并冠心病患者的临床资料,对症状、体征、证候、冠状动脉造影／CT结果等进行统计分析,总结2型糖尿病合并冠心病患者的临床特点和中医证候分布特点。
[结果]本组60例2型糖尿病合并冠心病患者年龄较大,以60岁以上老年患者为主,占78.3%,男女比例1.14：1；肥胖或超重者居多,分别占55.0%、11.7%；71.8%的男性患者有吸烟史。冠状动脉重度狭窄占68.3%,双支病变、三支病变分别占23.3%、65.0%。冠状动脉三支病变组年龄(70.53±8.88岁)最大,与单支病变组(60.29±10.42岁)比较具有统计学差异(P<0.05)。患者多合并高血压、血脂异常,分别占85.0%、80.0%,合并高血压或血脂异常患者的冠脉病变较不合并者严重,但未达到统计学差异。本组患者心血管系统症状不典型,40.00%及26.67%有胸闷、心悸,18.33%的患者有胸痛。中医辨证分型主证以气阴两虚为主,占81.6%,阴阳两虚证者冠状动脉三支病变、重度狭窄比率最大,气阴两虚证者次之,阴虚热盛证者比率最小,表现出从阴虚热盛到气阴两虚,再到阴阳两虚冠状动脉病变范围逐渐增大,病变程度逐渐加重的趋势,但未达统计学差异。兼证证型中,兼血瘀者最多(78.3%),其次为兼痰浊者(48.3%)；痰瘀互阻者17例,占28.33%,为复合兼证证型最多。兼证的比较中未显示出与冠脉病变的相关性。兼痰浊证组患者BMI最大(25.73±2.84kg／m2),与非痰浊证者相比,具有统计学差异(P<0.05)
[结论]本组60例2型糖尿病合并冠心病患者年龄较大,肥胖或超重者居多,多合并高血压病、血脂异常,男性患者多有吸烟史。患者冠脉病变以双支、三支病变,重度病变为主。
中医证型分析示2型糖尿病合并冠心病是本虚标实之证,本虚以气阴两虚为主,标实多为血瘀、痰浊,且多表现为痰瘀互阻。瘀血作为糖尿病的病理产物,在2型糖尿病合并冠心病的发展过程中具有重要的作用。在临床治疗时,应注意益气养阴,活血化瘀方法的使用。
肥胖是糖尿病及冠心病的重要危险因素,痰浊与肥胖相关,化痰祛浊、控制体重,是治疗2型糖尿病合并冠心病的重要组成部分。
Objective:explore the characteristics of traditional Chinese medicine syndromes of the Type 2 Diabetes Mellitus Patients with Coronary Heart Disease.
Method:The 60 cases of Type 2 Diabetes Mellitus Patients with Coronary Heart Disease from Jan,2007 to Dec 2009 were systemically reviewed in this clinical tria. The symptoms, TCM Syndrome differentions, BMI, blood pressure, blood lipids, physical and chemical inspection were statistically analyzed, the clinical characteristics and the principle of TCM patterns changes in the Type 2 Diabetes Mellitus Patients with Coronary Heart was summarized.
Result:Most of the Type 2 Diabetes Mellitus Patients with Coronary Heart Disease in this group are old persons,78.3% of them are older than 60 years old.The ratio of men to women was 1.14 to 1.The patients who were Obese or overweight were in the majority, accounting for 55.0% and 11.7%.71.8% of male patients are smokers. the Type 2 Diabetic Patients with Coronary Heart Disease are characteristic of diffuse coronary artery disease and narrow serious. Severe coronary artery stenosis accounting for 68.3%.double and triple vessel lesions accounting for 23.3% and 65.0%.Many patients with hypertension and dyslipidemia,accounting for 85.00% and 80.0%.Patients'symptoms of cardiovascular system were atypical.40.00% and 26.67% of patients feel chest tightness and palpitations,18.33% of patients feel Heartache.Qi-yin syndrome was the largest in deficiency syndromes, accounting for 81.6%.Patients who lack both yin and yang are characteristic of diffuse coronary artery disease and narrow serious.blood stasis was the largest in excess syndromes. accounting for 78.3%. blood-phlegm stasis accounting for 28.33%.patients combine with turbid phlegm obstructing have maximum BMI (25.73±2.84kg/m2)
Conclusion:In this clinical trial, Most of the Type 2 Diabetes Mellitus Patients with Coronary Heart Disease are old persons, The patients who were obese or overweight were in the majority, Many patients with hypertension and dyslipidemia. The Type 2 Diabetes Mellitus combine with Coronary Heart Disease is disease with deficiency in the root and excess in the branch, the most syndromes of the Type 2 Diabetes Mellitus Patients with Coronary Heart Disease were qi and Yin Deficiency. Blood stasis as a pathological product of diabetes, played an important role in the process of development of the disease. We can include that, in the clinical treatment of the Type 2 Diabetes Mellitus Patients with Coronary Heart Disease, the methods of replenishing qi and nourishing yin,promoting blood circulation by removing stasis should be used properly. obesity are important risk factors for Diabetes and coronary heart disease.Phlegm and obesity are closely related. Removing the phlegm turbidity and Weight control are important parts of Treatment of the Type 2 Diabetes Mellitus combine with Coronary Heart Disease. We should make full use of the principle of preventing possible disease, in order to prevent the disease's further development, and improve the quality of survival and life of patients.
[方法]调查2007年1月～2009年12月于北京医院中医科门诊及病房诊治的2型糖尿病合并冠心病患者的临床资料,对症状、体征、证候、冠状动脉造影／CT结果等进行统计分析,总结2型糖尿病合并冠心病患者的临床特点和中医证候分布特点。
[结果]本组60例2型糖尿病合并冠心病患者年龄较大,以60岁以上老年患者为主,占78.3%,男女比例1.14：1；肥胖或超重者居多,分别占55.0%、11.7%；71.8%的男性患者有吸烟史。冠状动脉重度狭窄占68.3%,双支病变、三支病变分别占23.3%、65.0%。冠状动脉三支病变组年龄(70.53±8.88岁)最大,与单支病变组(60.29±10.42岁)比较具有统计学差异(P<0.05)。患者多合并高血压、血脂异常,分别占85.0%、80.0%,合并高血压或血脂异常患者的冠脉病变较不合并者严重,但未达到统计学差异。本组患者心血管系统症状不典型,40.00%及26.67%有胸闷、心悸,18.33%的患者有胸痛。中医辨证分型主证以气阴两虚为主,占81.6%,阴阳两虚证者冠状动脉三支病变、重度狭窄比率最大,气阴两虚证者次之,阴虚热盛证者比率最小,表现出从阴虚热盛到气阴两虚,再到阴阳两虚冠状动脉病变范围逐渐增大,病变程度逐渐加重的趋势,但未达统计学差异。兼证证型中,兼血瘀者最多(78.3%),其次为兼痰浊者(48.3%)；痰瘀互阻者17例,占28.33%,为复合兼证证型最多。兼证的比较中未显示出与冠脉病变的相关性。兼痰浊证组患者BMI最大(25.73±2.84kg／m2),与非痰浊证者相比,具有统计学差异(P<0.05)
[结论]本组60例2型糖尿病合并冠心病患者年龄较大,肥胖或超重者居多,多合并高血压病、血脂异常,男性患者多有吸烟史。患者冠脉病变以双支、三支病变,重度病变为主。
中医证型分析示2型糖尿病合并冠心病是本虚标实之证,本虚以气阴两虚为主,标实多为血瘀、痰浊,且多表现为痰瘀互阻。瘀血作为糖尿病的病理产物,在2型糖尿病合并冠心病的发展过程中具有重要的作用。在临床治疗时,应注意益气养阴,活血化瘀方法的使用。
肥胖是糖尿病及冠心病的重要危险因素,痰浊与肥胖相关,化痰祛浊、控制体重,是治疗2型糖尿病合并冠心病的重要组成部分。
Objective:explore the characteristics of traditional Chinese medicine syndromes of the Type 2 Diabetes Mellitus Patients with Coronary Heart Disease.
Method:The 60 cases of Type 2 Diabetes Mellitus Patients with Coronary Heart Disease from Jan,2007 to Dec 2009 were systemically reviewed in this clinical tria. The symptoms, TCM Syndrome differentions, BMI, blood pressure, blood lipids, physical and chemical inspection were statistically analyzed, the clinical characteristics and the principle of TCM patterns changes in the Type 2 Diabetes Mellitus Patients with Coronary Heart was summarized.
Result:Most of the Type 2 Diabetes Mellitus Patients with Coronary Heart Disease in this group are old persons,78.3% of them are older than 60 years old.The ratio of men to women was 1.14 to 1.The patients who were Obese or overweight were in the majority, accounting for 55.0% and 11.7%.71.8% of male patients are smokers. the Type 2 Diabetic Patients with Coronary Heart Disease are characteristic of diffuse coronary artery disease and narrow serious. Severe coronary artery stenosis accounting for 68.3%.double and triple vessel lesions accounting for 23.3% and 65.0%.Many patients with hypertension and dyslipidemia,accounting for 85.00% and 80.0%.Patients'symptoms of cardiovascular system were atypical.40.00% and 26.67% of patients feel chest tightness and palpitations,18.33% of patients feel Heartache.Qi-yin syndrome was the largest in deficiency syndromes, accounting for 81.6%.Patients who lack both yin and yang are characteristic of diffuse coronary artery disease and narrow serious.blood stasis was the largest in excess syndromes. accounting for 78.3%. blood-phlegm stasis accounting for 28.33%.patients combine with turbid phlegm obstructing have maximum BMI (25.73±2.84kg/m2)
Conclusion:In this clinical trial, Most of the Type 2 Diabetes Mellitus Patients with Coronary Heart Disease are old persons, The patients who were obese or overweight were in the majority, Many patients with hypertension and dyslipidemia. The Type 2 Diabetes Mellitus combine with Coronary Heart Disease is disease with deficiency in the root and excess in the branch, the most syndromes of the Type 2 Diabetes Mellitus Patients with Coronary Heart Disease were qi and Yin Deficiency. Blood stasis as a pathological product of diabetes, played an important role in the process of development of the disease. We can include that, in the clinical treatment of the Type 2 Diabetes Mellitus Patients with Coronary Heart Disease, the methods of replenishing qi and nourishing yin,promoting blood circulation by removing stasis should be used properly. obesity are important risk factors for Diabetes and coronary heart disease.Phlegm and obesity are closely related. Removing the phlegm turbidity and Weight control are important parts of Treatment of the Type 2 Diabetes Mellitus combine with Coronary Heart Disease. We should make full use of the principle of preventing possible disease, in order to prevent the disease's further development, and improve the quality of survival and life of patients.
引文
[1]International Diabetes Federation:Diabetes and impaired glu-cose tolerance: prevalence and projections In:Diabetes Atlas 2ndedition [M] World Diabetes Foundation.2003.17.
[2]Haffner SM, Lehto S, RonnemaaT, et a. Mortality from coronaryheartdisease in subjects with type 2 diabetes and in nondiabetic subjects with and without priormyocardial infarction [J]. New England journal of Medicine,1998,339: 229.
[3]David MN, James M, Daniedl ES. The epidemiology of cardiovascular disease in type 2 diabetes mellitus:howsweet it is or is it [J].The Lancet,1997,7: 514-515.
[4]Haffner SM, Lehto S et all. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction[J]. N Engl J Med 1998,339(4):229-234.
[5]Gray RP, Yudkin JS. Chapter. Cardiova scular disease indiabetes mellitus[M]. Textbook of Diabetes, JC Pickup, G Williams. Oxford:Black mell Sciences Ltd, 1997
[6]袁申元,朱良湘,胡虹莺等.北京地区20 682人群糖尿病筛查及1566人OGTT的研究[J].中华内分泌代谢杂志,1997,13(2)：69-72.
[7]刘英哲,陈泽奇,张清梅等.1433例2型糖尿病及并发症临床流行病学调查[J].中国医师杂志2005,7(5)：607-609.
[8]郭立新,王晓霞,李东晓等.老年2型糖尿病患者死因分析(附尸检报告)[J].中国糖尿病杂志,2006,14(3)：201-204.
[9]王瑞萍,钱贻简,陈曼丽等,老年人糖尿病心脏病的临床及病理改变[J].中华内科杂志,1998,37(10)：677.
[10]杨锦民,姚彦.糖尿病合并急性心肌梗死36例相关因素分析[J].陕西医学杂志.2006,35(7)：849-851.
[12]陈简庆,郭小梅.冠心病合并糖尿病临床特点分析[J].当代医学,2009,15(9)：78-79
[13]李平.糖尿病性冠心病临床特点分析[J].中国误诊学杂志,2006,6(11)：2114-2115
[14]焦方惠,糖尿病性冠心病心肌缺血的动态心电图分析[J].社区医学志,2006,4(8)：39-40.
[15]迟家敏,孙福成.实用糖尿病学[M].北京.人民卫生出版社,2009,第三版：434
[16]刘奕,付强,黄宜杰.合并11型糖尿病的冠心病患者临床心电图及冠状动脉病变特征 分析[J].医学信息.2005,18(12)：1724-1726.
[17]佟子川,崔亮,曹树军等.合并糖尿病的心绞痛患者冠状动脉内超声影像特点的分析[J].中国医药导刊,2006,8(6)：412-413.
[18]张秀洲,宫建丽,李文华等.股动脉超声预测糖尿病患者冠状动脉病变严重程度的意义[J].中国糖尿病杂志,2007,15(12)：738-739.
[19]王熙然,裴育,白玉蓉等.骨密度变化与2型糖尿病合并冠状动脉粥样硬化性心脏病患者踝肱指数的关系[J].中国组织工程研究与临床床康复,2008,12(20)：3897-3900.
[20]马建林,李新明,王圣等.冠心病并发Ⅱ型糖尿病患者高凝状态的临床研究[J].心脏杂志,2006,18(6)：661-663.
[21]姜云发,谷新顺,郝国贞等.急性冠状动脉综合征合并糖尿病患者纤溶系统及血小板功能的研究——附68例报告[J].新医学,2007,38(10)：661-663.
[22]李月华,姜坚,刘晓红等.伴微量白蛋白尿的2型糖尿病患者并发冠状动脉粥样硬化性心脏病的危险性[J].中国组织工程研究与临床康复,2007,11(39)：7725-7727.
[23]吴琪.血清尿酸对冠心病并糖尿病患者PCI术后再狭窄的影响.[J].心血管康复医学杂志,2006,15(6)：546-547.
[24]雒瑢,樊继援.血尿酸与2型糖尿病及并发冠心病的关系[J].中国糖尿病杂志,2006,14(1)：20-22.
[25]钱远宇,孟庆义,杨晓秋等.老年2型糖尿病合并高尿酸与心室重构的关系[J].天津医药,2007,35(4)：288-289.
[26]李建英,黄从新,王凤.2型糖尿病并发冠心病老年患者血清总同型半胱氨酸与胰岛素敏感性的关系[J].广西医科大学学报,2006,23(2)：264-265.
[27]苏振诚.2型糖尿病并发冠心病患者血同型半胱氨酸测定的意义[J].中国老年学杂志2007,27(3)：282-289.
[28]刘文卫,刘永,江华等.冠心病合并2型糖尿病患者血清白介素-18水平检测[J].中国医师杂志,2007,9(6)：834-835.
[29]李林锋,洪浪,王洪等.2型糖尿病患者血清HSP60水平与冠状动脉病变的关系[J].江西医学院学报,2007,47(4)：60-62.
[30]冯自明,李温斌.冠心病并发糖尿病患者血清铜含量变化的临床研究[J].中国煤炭工业医学杂志,2006,9(6)：589.
[31]石绮屏,冯烈,任强.糖尿病合并冠心病患者可溶性血管细胞黏附分子1的变化[J].中国糖尿病杂志.,2006,14(2)：108.
[32]陆林,蒲里津,张奇等.2型糖尿病患者血清糖化白蛋白水平与冠状动脉病变程度的关系[J].中国循环杂志,2007,22(5)：343-346.
[33]林少达,林楚佳,黄天华等.2型糖尿病合并冠心病患者的促心肌素-1水平[J].中国糖尿病杂志,2007,15(4)：233-234.
[34]窦学荣,徐红,王伯松等.冠心病合并糖尿病人群血清脂联素水平研究[J].泰山医学院学报,2006,27(7)：640-642.
[35]王福莉,刘国良,糖尿病伴冠心病患者血浆游离肉碱水平的相关性研究[J].中国误诊学杂志,2006,6(19)：3687-3688.
[36]范杰,高卫国,赵素斌.2型糖尿病合并冠心病患者血清中胆红素和尿酸水平的变化[J].陕西医学杂志,2007,36(12)：1692-1693
[37]雒瑢,樊继援,张鹏等.内皮型一氧化氮合酶基因多态性与2型糖尿病并发冠心病的相关性研究[J].中国医师杂志,2006,8(1)：5-7.
[38]向光大,刘宏,侯洁等.内皮一氧化氮合酶基因5′-侧翼区T-786→C突变与2型糖尿病并发冠心病的关系[J].中国糖尿病杂志,2006,14(1)：14-17.
[39]张丽,赵家军,唐宽晓等.A1166C基因多态性与2型糖尿病并发冠心病、心肌梗死相关性的研究[J].山东大学学报(医学版),2005,43(11)：1034-1037.
[41]杨进刚.降糖目标无过血糖控制强调个体化——ADA/ACCF/AHA针对ACCORD、 ADVANCE和VADT试验发布联合声明[J].心血管病学进展,2009,30(1)：18-20.
[42]Steinhubl SR, Berger PB, Mann JT 3 rd, et a.l Early and sustaineddual oral antip latelet therapy following percutaneous coronary inter vention:a random ized controlledtrial[J]. JAMA,2002,288 (19):241122420.
[43]Budaj A, Yusuf S, Mehta SR, et al. Benefit of clop idogrel in patients with acute coronary syndromes without ST segment elevation in various risk groups[J]. Circulation,2002,106 (13):162221626.
[44]胡大一.综合控制糖尿病患者心血管疾病的多重危险因素———从UKPDS到CARDS[J].中国医刊,2004,39(7)：59.
[45]《中国成人血脂异常防治指南》制定联合委员会.中国成人血脂异常防治指南[S].北京：人民卫生出版社,2007：38240.
[46]王姮,杨永年.糖尿病现代治疗学[M].北京：科学出版2005：2212227.
[47]Gottlieb SS,Mc Carter RJ, Vogel RA. Effect of beta blocker on mortality among high risk and low risk patients after myocardial infarction [J]. N Engl J Med,1998,339 (8):4892497.
[48]Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effect of ram ip ril on cardiovascular and microvascular out comes in people with diabetes mellitus:results of the HOPE study HOP[J]. Lancet,2000,355 (9022):2532259.
[49]Sabate M, Jimenez-Quevedo P, Angiolillo DJ, et al. Randomized comparison of sirolimus-eluting stent versus standard stent forpercutaneous coronary revascularization in diabetes patients[J]. Circulation,2005,112:2175-2183.
[50]杨晓晖,钟柳娜,吕仁和.糖尿病心脏病中医药临床研究述评[J].中国医药学报,2003,18(7)：430-434.
[51]王洪武,倪青,林兰治疗糖尿病合并冠心病的辨治思路[J].中华中医药杂志(原中国医药报),2009,24(3)：334-337.
[52]王琪,李延.中医药治疗糖尿病合并冠心病心绞痛的研究进展[J].世界中西医结合杂志,2008,3(12)：750-752.
[53]杨兵,梁翠微.老年糖尿病合并冠心病中医辨治探讨[J].光明中医,2005,20(4)：30-31.
[54]栗明,栗德林,于阳等.栗德林教授关于糖尿病并发冠心病中医病机新理论简介[N].天津中医药大学学报,2008,27(4)：250-251.
[55]李步满,吴深涛,吴丽丽.2型糖尿病血管并发症与“阴火”病机的相关性探讨[J].辽宁中医杂志,2007,34(9)：1229-1231.
[56]朱明丹,杜武勋,刘长玉等.糖尿病性冠心病从虚热瘀毒论治[J].辽宁中医杂志.2007,34(11)：1549-1550.
[57]洪敏,李新梅,雷达.糖尿病冠心病本虚标实证型分布特征及与病程年龄关系初探[J].河南中医,2007,27(3)：39-41.
[58]李锋,王长海,王海平等.糖尿病合并冠心病患者冠脉病变程度及中医证型特点分析[N].第四军医大学学报,2000,21(10)：1206-1208.
[59]邢雁伟,王阶,高永红等.冠心病合并糖尿病患者冠脉病变及中医证候学特点[J].中国中医药信息杂志,2007,14(9)：20-21.
[60]李立凤,冯利.106例糖尿病性冠心病中医证候调查分析[J].长春中医药大学学报.2009,25(2)：192-193.
[61]董梅,张军平.从冠心病保护因素的角度探讨中医药对糖尿病心血管事件的预防作用[J].中医中药,2008,5(2)：82-83.
[62]高莹.辨证分型治疗糖尿病合并冠心病62例分析[J].中医药学刊,2003,21(2)：151-155.
[63]王映坤.中医药治疗糖尿病及其并发症56例疗效观察[J].云南中医杂志,1994,15(3)：1-5.
[64]许莉嘉,凌在荣,王燕.糖尿病合并冠心病辨治体会[J].中国中医药信息志,2006,13(6)：79.
[65]张欣,孙小东.辨治糖尿病并发冠心病32例[J].辽宁中医杂志,2003,30(8)：614-615.
[66]朱立群.糖尿病心脏病的中西医治疗[J].糖尿病新世界,2005,3：18-19.
[67]胡东鹏,倪青.巧定病性明标本,中医合参论治疗-林兰辨治糖尿病心脏病的经验[J].辽宁中医杂志,2000,27(7)：289.
[68]孙宇新.益心通脉方对糖尿病性冠心病患者纤溶系统的干预研究[J].山东中医杂志,2007,26(7)：450-451.
[69]陈大舜,徐梓辉.2型糖尿病并发冠心病的中医辨病论治研究[N].湖南中医学院学报2003；23(1)：2-6.
[70]林兰,张润云,倪青等.糖心平治疗糖尿病冠心病的临床研究[J].中国中医药信息杂志,2000,7(8)：46.
[71]王津文,张玉,渠莉.参芦颗粒对2型糖尿病合并冠心病患者血浆内皮素与一氧化氮水平的影响[J].中国现代药物应用,2008,2(5)：32-35.
[72]刘成.中西医结合治疗糖尿病性冠心病心绞痛心衰32例疗效观察[N]长春中医学院学报,2004,20(1)：14.
[73]韩文宝.益气通络胶囊治疗糖尿病合并冠心病心绞痛60例临床观察[J].中国现代医药杂志,2007,8(9)：78-79.
[74]孙元莹,郭茂松,吴春萍等.参乌冠心冲剂治疗糖尿病性冠心病45例观察[J].长春中医药大学学报,2006,22(4)：19-21.
[75]李予蓉.双参胶囊治疗糖尿病性心脏病临床疗效观察[J].心脏杂志(Chin Heart J)2000,12(3)：209-210.
[76]吴永健.糖尿病患者冠心病的治疗[J].药品评价,2008,5(8)：358-360.
[77]张晨君,郑智红,木尼拉.糖尿病合并冠心病患者冠状动脉病变与颈动脉超声的关系[J].实用心脑肺血管病杂志,2009,17(4)：243-245.
[78]刘晓红,来春林,张锦等.冠心病合并2型糖尿病患者冠脉斑块的评价[J].中西医结合心脑血管病杂志,2009,7(1)：17-18.
[79]卢娟等.2型糖尿病合并冠心病患者冠状动脉病变的特点和心功能的变化[J].中国误诊学杂志,2009,9(6)：1312-1313.
[80]蔡昕华.对肥胖病症病因及治疗方向的探讨[J].中国中医药,2009,7(9)：2.
[81]邓杰.冠心病合并肥胖者的中医病理因素分析[J].江苏中医药,2008,40(4)：24-25.
[82]叶威巍.脂肪组织的内分泌功能研究进展[J].中华医学研究杂志,2006,6(4)：332-335.
[83]StamlerJ, VaccaroO, NeatonJD, et a.l Diabetes, other risk factors, and 12-yr cardiovascularmortality formen screened in the Multiple Risk Factor Intervention Trial [J]. Diabetes Care,1993,16:434.
[84]中华医学会心血管病学分会.全国冠心病与糖尿病关系研讨会纪要[J].中华心血管 病,2004,32(2)：183.
[85]The Action to Control Cardiovascular Risk in Diabetes (ACCORD)Study Group. Effects of intensiveglucose lowering in type 2 diabetes. N Engl J Med 2008,358(24):2545-2559.
[86]ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide onmacrovascular and microvascular outcomes in patients with type 2 diabetes mellitus(the ADVANCE trial):a randomized controlled trial [J]. Lancet,2007,370(9590):829-840.
[87]ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 2008 Jun12；358(24)：2560-2572.
[88]丁邦晗,张敏州,吕强等.胸痹心痛并发高血压、糖尿病的临床证型特点分析[J].中西医结合心脑血管病杂志,2004,2(3)：125-127.
[89]安超.冠心病中医证候特点与冠脉病变程度相关性的临床研究——502例冠脉造影患者中医证候临床调查,
[90]Frishman W H, Retter A, Mobati D, et al. Innovative drug target sfor t reating cardiovascular disease:adhesion molecules, cyto kines, neuropeptide Y, calcineurin, bradykinin, urotensin,and heat shockp rotein[M] Frishman W H, Sonnenblick E H, Sica D. Cardiovas2cular Pharmacot herapeutics.2nd ed.New York:Mc Graw Hill,2003:705—739.
[91]Falcone C, Nespoli L, Geroldi D, et al. Dilent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease [J].Int J Cardiol,2003,90:219—227.
[94]崔伯乐.1000例老年2型糖尿病患者中医证候规律研究.北京中医药大学硕士研究生论文.2009.
[95]焦方惠.糖尿病性冠心病心肌缺血的动态心电图分析[J].社区医学杂志,2006,4(8)：39-40.
[96]刘毅.2型糖尿病合并冠心病患者的中医证候特点.北京中医药大学硕士研究生论文.2008.
[98]胡大一,杨进刚.关注冠心病患者的糖代谢异常[J].中华内科杂志,2006,45(10)：7932795.
[99]MALID S, WONG N D, FRANKLIN S S, et al. Impact of thmetabolic syndrome onmortality from coronary heart disease, car-diovascular disease, and all causes in United States adults [J] Circulation,2004,110 (10):1245-1250.
[100]WONG N D, PIO JR, FRANKLIN S S, et al. Preventing coro-nary events by optimal control of blood pressure and lipids in pa-tientswith themetabolic syndrome[J] Am J Cardio,l 2003,9(12):1421-1426.
[101]American Diabetes Association:Implications of the Dia-betes Control and Complications Trial. Diabetes Care 2000,23(Suppl 1):S24.
[102]American Diabetes Association:Implications of the UnitedKingdom Prospective Diabetes Study Diabetes Care 2000,23(Suppl 1):S27.
[2]Haffner SM, Lehto S, RonnemaaT, et a. Mortality from coronaryheartdisease in subjects with type 2 diabetes and in nondiabetic subjects with and without priormyocardial infarction [J]. New England journal of Medicine,1998,339: 229.
[3]David MN, James M, Daniedl ES. The epidemiology of cardiovascular disease in type 2 diabetes mellitus:howsweet it is or is it [J].The Lancet,1997,7: 514-515.
[4]Haffner SM, Lehto S et all. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction[J]. N Engl J Med 1998,339(4):229-234.
[5]Gray RP, Yudkin JS. Chapter. Cardiova scular disease indiabetes mellitus[M]. Textbook of Diabetes, JC Pickup, G Williams. Oxford:Black mell Sciences Ltd, 1997
[6]袁申元,朱良湘,胡虹莺等.北京地区20 682人群糖尿病筛查及1566人OGTT的研究[J].中华内分泌代谢杂志,1997,13(2)：69-72.
[7]刘英哲,陈泽奇,张清梅等.1433例2型糖尿病及并发症临床流行病学调查[J].中国医师杂志2005,7(5)：607-609.
[8]郭立新,王晓霞,李东晓等.老年2型糖尿病患者死因分析(附尸检报告)[J].中国糖尿病杂志,2006,14(3)：201-204.
[9]王瑞萍,钱贻简,陈曼丽等,老年人糖尿病心脏病的临床及病理改变[J].中华内科杂志,1998,37(10)：677.
[10]杨锦民,姚彦.糖尿病合并急性心肌梗死36例相关因素分析[J].陕西医学杂志.2006,35(7)：849-851.
[12]陈简庆,郭小梅.冠心病合并糖尿病临床特点分析[J].当代医学,2009,15(9)：78-79
[13]李平.糖尿病性冠心病临床特点分析[J].中国误诊学杂志,2006,6(11)：2114-2115
[14]焦方惠,糖尿病性冠心病心肌缺血的动态心电图分析[J].社区医学志,2006,4(8)：39-40.
[15]迟家敏,孙福成.实用糖尿病学[M].北京.人民卫生出版社,2009,第三版：434
[16]刘奕,付强,黄宜杰.合并11型糖尿病的冠心病患者临床心电图及冠状动脉病变特征 分析[J].医学信息.2005,18(12)：1724-1726.
[17]佟子川,崔亮,曹树军等.合并糖尿病的心绞痛患者冠状动脉内超声影像特点的分析[J].中国医药导刊,2006,8(6)：412-413.
[18]张秀洲,宫建丽,李文华等.股动脉超声预测糖尿病患者冠状动脉病变严重程度的意义[J].中国糖尿病杂志,2007,15(12)：738-739.
[19]王熙然,裴育,白玉蓉等.骨密度变化与2型糖尿病合并冠状动脉粥样硬化性心脏病患者踝肱指数的关系[J].中国组织工程研究与临床床康复,2008,12(20)：3897-3900.
[20]马建林,李新明,王圣等.冠心病并发Ⅱ型糖尿病患者高凝状态的临床研究[J].心脏杂志,2006,18(6)：661-663.
[21]姜云发,谷新顺,郝国贞等.急性冠状动脉综合征合并糖尿病患者纤溶系统及血小板功能的研究——附68例报告[J].新医学,2007,38(10)：661-663.
[22]李月华,姜坚,刘晓红等.伴微量白蛋白尿的2型糖尿病患者并发冠状动脉粥样硬化性心脏病的危险性[J].中国组织工程研究与临床康复,2007,11(39)：7725-7727.
[23]吴琪.血清尿酸对冠心病并糖尿病患者PCI术后再狭窄的影响.[J].心血管康复医学杂志,2006,15(6)：546-547.
[24]雒瑢,樊继援.血尿酸与2型糖尿病及并发冠心病的关系[J].中国糖尿病杂志,2006,14(1)：20-22.
[25]钱远宇,孟庆义,杨晓秋等.老年2型糖尿病合并高尿酸与心室重构的关系[J].天津医药,2007,35(4)：288-289.
[26]李建英,黄从新,王凤.2型糖尿病并发冠心病老年患者血清总同型半胱氨酸与胰岛素敏感性的关系[J].广西医科大学学报,2006,23(2)：264-265.
[27]苏振诚.2型糖尿病并发冠心病患者血同型半胱氨酸测定的意义[J].中国老年学杂志2007,27(3)：282-289.
[28]刘文卫,刘永,江华等.冠心病合并2型糖尿病患者血清白介素-18水平检测[J].中国医师杂志,2007,9(6)：834-835.
[29]李林锋,洪浪,王洪等.2型糖尿病患者血清HSP60水平与冠状动脉病变的关系[J].江西医学院学报,2007,47(4)：60-62.
[30]冯自明,李温斌.冠心病并发糖尿病患者血清铜含量变化的临床研究[J].中国煤炭工业医学杂志,2006,9(6)：589.
[31]石绮屏,冯烈,任强.糖尿病合并冠心病患者可溶性血管细胞黏附分子1的变化[J].中国糖尿病杂志.,2006,14(2)：108.
[32]陆林,蒲里津,张奇等.2型糖尿病患者血清糖化白蛋白水平与冠状动脉病变程度的关系[J].中国循环杂志,2007,22(5)：343-346.
[33]林少达,林楚佳,黄天华等.2型糖尿病合并冠心病患者的促心肌素-1水平[J].中国糖尿病杂志,2007,15(4)：233-234.
[34]窦学荣,徐红,王伯松等.冠心病合并糖尿病人群血清脂联素水平研究[J].泰山医学院学报,2006,27(7)：640-642.
[35]王福莉,刘国良,糖尿病伴冠心病患者血浆游离肉碱水平的相关性研究[J].中国误诊学杂志,2006,6(19)：3687-3688.
[36]范杰,高卫国,赵素斌.2型糖尿病合并冠心病患者血清中胆红素和尿酸水平的变化[J].陕西医学杂志,2007,36(12)：1692-1693
[37]雒瑢,樊继援,张鹏等.内皮型一氧化氮合酶基因多态性与2型糖尿病并发冠心病的相关性研究[J].中国医师杂志,2006,8(1)：5-7.
[38]向光大,刘宏,侯洁等.内皮一氧化氮合酶基因5′-侧翼区T-786→C突变与2型糖尿病并发冠心病的关系[J].中国糖尿病杂志,2006,14(1)：14-17.
[39]张丽,赵家军,唐宽晓等.A1166C基因多态性与2型糖尿病并发冠心病、心肌梗死相关性的研究[J].山东大学学报(医学版),2005,43(11)：1034-1037.
[41]杨进刚.降糖目标无过血糖控制强调个体化——ADA/ACCF/AHA针对ACCORD、 ADVANCE和VADT试验发布联合声明[J].心血管病学进展,2009,30(1)：18-20.
[42]Steinhubl SR, Berger PB, Mann JT 3 rd, et a.l Early and sustaineddual oral antip latelet therapy following percutaneous coronary inter vention:a random ized controlledtrial[J]. JAMA,2002,288 (19):241122420.
[43]Budaj A, Yusuf S, Mehta SR, et al. Benefit of clop idogrel in patients with acute coronary syndromes without ST segment elevation in various risk groups[J]. Circulation,2002,106 (13):162221626.
[44]胡大一.综合控制糖尿病患者心血管疾病的多重危险因素———从UKPDS到CARDS[J].中国医刊,2004,39(7)：59.
[45]《中国成人血脂异常防治指南》制定联合委员会.中国成人血脂异常防治指南[S].北京：人民卫生出版社,2007：38240.
[46]王姮,杨永年.糖尿病现代治疗学[M].北京：科学出版2005：2212227.
[47]Gottlieb SS,Mc Carter RJ, Vogel RA. Effect of beta blocker on mortality among high risk and low risk patients after myocardial infarction [J]. N Engl J Med,1998,339 (8):4892497.
[48]Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effect of ram ip ril on cardiovascular and microvascular out comes in people with diabetes mellitus:results of the HOPE study HOP[J]. Lancet,2000,355 (9022):2532259.
[49]Sabate M, Jimenez-Quevedo P, Angiolillo DJ, et al. Randomized comparison of sirolimus-eluting stent versus standard stent forpercutaneous coronary revascularization in diabetes patients[J]. Circulation,2005,112:2175-2183.
[50]杨晓晖,钟柳娜,吕仁和.糖尿病心脏病中医药临床研究述评[J].中国医药学报,2003,18(7)：430-434.
[51]王洪武,倪青,林兰治疗糖尿病合并冠心病的辨治思路[J].中华中医药杂志(原中国医药报),2009,24(3)：334-337.
[52]王琪,李延.中医药治疗糖尿病合并冠心病心绞痛的研究进展[J].世界中西医结合杂志,2008,3(12)：750-752.
[53]杨兵,梁翠微.老年糖尿病合并冠心病中医辨治探讨[J].光明中医,2005,20(4)：30-31.
[54]栗明,栗德林,于阳等.栗德林教授关于糖尿病并发冠心病中医病机新理论简介[N].天津中医药大学学报,2008,27(4)：250-251.
[55]李步满,吴深涛,吴丽丽.2型糖尿病血管并发症与“阴火”病机的相关性探讨[J].辽宁中医杂志,2007,34(9)：1229-1231.
[56]朱明丹,杜武勋,刘长玉等.糖尿病性冠心病从虚热瘀毒论治[J].辽宁中医杂志.2007,34(11)：1549-1550.
[57]洪敏,李新梅,雷达.糖尿病冠心病本虚标实证型分布特征及与病程年龄关系初探[J].河南中医,2007,27(3)：39-41.
[58]李锋,王长海,王海平等.糖尿病合并冠心病患者冠脉病变程度及中医证型特点分析[N].第四军医大学学报,2000,21(10)：1206-1208.
[59]邢雁伟,王阶,高永红等.冠心病合并糖尿病患者冠脉病变及中医证候学特点[J].中国中医药信息杂志,2007,14(9)：20-21.
[60]李立凤,冯利.106例糖尿病性冠心病中医证候调查分析[J].长春中医药大学学报.2009,25(2)：192-193.
[61]董梅,张军平.从冠心病保护因素的角度探讨中医药对糖尿病心血管事件的预防作用[J].中医中药,2008,5(2)：82-83.
[62]高莹.辨证分型治疗糖尿病合并冠心病62例分析[J].中医药学刊,2003,21(2)：151-155.
[63]王映坤.中医药治疗糖尿病及其并发症56例疗效观察[J].云南中医杂志,1994,15(3)：1-5.
[64]许莉嘉,凌在荣,王燕.糖尿病合并冠心病辨治体会[J].中国中医药信息志,2006,13(6)：79.
[65]张欣,孙小东.辨治糖尿病并发冠心病32例[J].辽宁中医杂志,2003,30(8)：614-615.
[66]朱立群.糖尿病心脏病的中西医治疗[J].糖尿病新世界,2005,3：18-19.
[67]胡东鹏,倪青.巧定病性明标本,中医合参论治疗-林兰辨治糖尿病心脏病的经验[J].辽宁中医杂志,2000,27(7)：289.
[68]孙宇新.益心通脉方对糖尿病性冠心病患者纤溶系统的干预研究[J].山东中医杂志,2007,26(7)：450-451.
[69]陈大舜,徐梓辉.2型糖尿病并发冠心病的中医辨病论治研究[N].湖南中医学院学报2003；23(1)：2-6.
[70]林兰,张润云,倪青等.糖心平治疗糖尿病冠心病的临床研究[J].中国中医药信息杂志,2000,7(8)：46.
[71]王津文,张玉,渠莉.参芦颗粒对2型糖尿病合并冠心病患者血浆内皮素与一氧化氮水平的影响[J].中国现代药物应用,2008,2(5)：32-35.
[72]刘成.中西医结合治疗糖尿病性冠心病心绞痛心衰32例疗效观察[N]长春中医学院学报,2004,20(1)：14.
[73]韩文宝.益气通络胶囊治疗糖尿病合并冠心病心绞痛60例临床观察[J].中国现代医药杂志,2007,8(9)：78-79.
[74]孙元莹,郭茂松,吴春萍等.参乌冠心冲剂治疗糖尿病性冠心病45例观察[J].长春中医药大学学报,2006,22(4)：19-21.
[75]李予蓉.双参胶囊治疗糖尿病性心脏病临床疗效观察[J].心脏杂志(Chin Heart J)2000,12(3)：209-210.
[76]吴永健.糖尿病患者冠心病的治疗[J].药品评价,2008,5(8)：358-360.
[77]张晨君,郑智红,木尼拉.糖尿病合并冠心病患者冠状动脉病变与颈动脉超声的关系[J].实用心脑肺血管病杂志,2009,17(4)：243-245.
[78]刘晓红,来春林,张锦等.冠心病合并2型糖尿病患者冠脉斑块的评价[J].中西医结合心脑血管病杂志,2009,7(1)：17-18.
[79]卢娟等.2型糖尿病合并冠心病患者冠状动脉病变的特点和心功能的变化[J].中国误诊学杂志,2009,9(6)：1312-1313.
[80]蔡昕华.对肥胖病症病因及治疗方向的探讨[J].中国中医药,2009,7(9)：2.
[81]邓杰.冠心病合并肥胖者的中医病理因素分析[J].江苏中医药,2008,40(4)：24-25.
[82]叶威巍.脂肪组织的内分泌功能研究进展[J].中华医学研究杂志,2006,6(4)：332-335.
[83]StamlerJ, VaccaroO, NeatonJD, et a.l Diabetes, other risk factors, and 12-yr cardiovascularmortality formen screened in the Multiple Risk Factor Intervention Trial [J]. Diabetes Care,1993,16:434.
[84]中华医学会心血管病学分会.全国冠心病与糖尿病关系研讨会纪要[J].中华心血管 病,2004,32(2)：183.
[85]The Action to Control Cardiovascular Risk in Diabetes (ACCORD)Study Group. Effects of intensiveglucose lowering in type 2 diabetes. N Engl J Med 2008,358(24):2545-2559.
[86]ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide onmacrovascular and microvascular outcomes in patients with type 2 diabetes mellitus(the ADVANCE trial):a randomized controlled trial [J]. Lancet,2007,370(9590):829-840.
[87]ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 2008 Jun12；358(24)：2560-2572.
[88]丁邦晗,张敏州,吕强等.胸痹心痛并发高血压、糖尿病的临床证型特点分析[J].中西医结合心脑血管病杂志,2004,2(3)：125-127.
[89]安超.冠心病中医证候特点与冠脉病变程度相关性的临床研究——502例冠脉造影患者中医证候临床调查,
[90]Frishman W H, Retter A, Mobati D, et al. Innovative drug target sfor t reating cardiovascular disease:adhesion molecules, cyto kines, neuropeptide Y, calcineurin, bradykinin, urotensin,and heat shockp rotein[M] Frishman W H, Sonnenblick E H, Sica D. Cardiovas2cular Pharmacot herapeutics.2nd ed.New York:Mc Graw Hill,2003:705—739.
[91]Falcone C, Nespoli L, Geroldi D, et al. Dilent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease [J].Int J Cardiol,2003,90:219—227.
[94]崔伯乐.1000例老年2型糖尿病患者中医证候规律研究.北京中医药大学硕士研究生论文.2009.
[95]焦方惠.糖尿病性冠心病心肌缺血的动态心电图分析[J].社区医学杂志,2006,4(8)：39-40.
[96]刘毅.2型糖尿病合并冠心病患者的中医证候特点.北京中医药大学硕士研究生论文.2008.
[98]胡大一,杨进刚.关注冠心病患者的糖代谢异常[J].中华内科杂志,2006,45(10)：7932795.
[99]MALID S, WONG N D, FRANKLIN S S, et al. Impact of thmetabolic syndrome onmortality from coronary heart disease, car-diovascular disease, and all causes in United States adults [J] Circulation,2004,110 (10):1245-1250.
[100]WONG N D, PIO JR, FRANKLIN S S, et al. Preventing coro-nary events by optimal control of blood pressure and lipids in pa-tientswith themetabolic syndrome[J] Am J Cardio,l 2003,9(12):1421-1426.
[101]American Diabetes Association:Implications of the Dia-betes Control and Complications Trial. Diabetes Care 2000,23(Suppl 1):S24.
[102]American Diabetes Association:Implications of the UnitedKingdom Prospective Diabetes Study Diabetes Care 2000,23(Suppl 1):S27.